Showing results (161-170 of 298) with videos related to
Sort By:
Pageof 30
The Prostate|January 1, 1995
A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasiaP H Gann, C H Hennekens, C Longcope, et al.JAMA|February 22, 2000
Oral androstenedione administration and serum testosterone concentrations in young menB Z Leder, C Longcope, D H Catlin, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1995
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year periodS E Hankinson, J E Manson, D Spiegelman, et al.The Journal of Clinical Endocrinology and Metabolism|May 11, 1991
Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to testosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivoR V Haning, C A Flood, R J Hackett, et al.European Journal of Endocrinology|July 25, 1998
Dehydroepiandrosterone sulfate does not prevent spontaneous and iodine-induced lymphocytic thyroiditis and diabetes mellitus in the BB/Wor ratS Alex, L E Braverman, S L Fang, et al.Archives of Internal Medicine|October 1, 1982
Systemic lupus erythematosus in men. Genetic and endocrine featuresR D Inman, L Jovanovic, J A Markenson, et al.JAMA|August 18, 1993
Topical anesthesia during circumcision in newborn infantsF Benini, C C Johnston, D Faucher, et al.Social Science & Medicine (1982)|June 1, 2000
Pain response in Chinese and non-Chinese Canadian infants: is there a difference?C Rosmus, C C Johnston, A Chan-Yip, et al.American Journal of Epidemiology|February 13, 2001
Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging StudyH A Feldman, C B Johannes, A B Araujo, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1993
Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropinsR V Haning, R J Hackett, C A Flood, et al.Pageof 30